Core Laboratories Statistics
Total Valuation
CLB has a market cap or net worth of $587.11 million. The enterprise value is $727.90 million.
| Market Cap | 587.11M |
| Enterprise Value | 727.90M |
Important Dates
The next estimated earnings date is Wednesday, October 22, 2025, after market close.
| Earnings Date | Oct 22, 2025 |
| Ex-Dividend Date | Aug 4, 2025 |
Share Statistics
CLB has 46.89 million shares outstanding. The number of shares has decreased by -0.02% in one year.
| Current Share Class | 46.89M |
| Shares Outstanding | 46.89M |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | +1.26% |
| Owned by Insiders (%) | 1.06% |
| Owned by Institutions (%) | 112.83% |
| Float | 46.38M |
Valuation Ratios
The trailing PE ratio is 20.18 and the forward PE ratio is 15.90.
| PE Ratio | 20.18 |
| Forward PE | 15.90 |
| PS Ratio | 1.12 |
| Forward PS | n/a |
| PB Ratio | 2.20 |
| P/TBV Ratio | 3.74 |
| P/FCF Ratio | 14.78 |
| P/OCF Ratio | 10.69 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.61, with an EV/FCF ratio of 18.53.
| EV / Earnings | 24.57 |
| EV / Sales | 1.41 |
| EV / EBITDA | 11.61 |
| EV / EBIT | 15.17 |
| EV / FCF | 18.53 |
Financial Position
The company has a current ratio of 2.27, with a Debt / Equity ratio of 0.67.
| Current Ratio | 2.27 |
| Quick Ratio | 1.52 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 2.16 |
| Debt / FCF | 4.55 |
| Interest Coverage | 4.34 |
Financial Efficiency
Return on equity (ROE) is 11.78% and return on invested capital (ROIC) is 6.72%.
| Return on Equity (ROE) | 11.78% |
| Return on Assets (ROA) | 5.00% |
| Return on Invested Capital (ROIC) | 6.72% |
| Return on Capital Employed (ROCE) | 9.65% |
| Revenue Per Employee | $147,822 |
| Profits Per Employee | $8,466 |
| Employee Count | 3,500 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 6.42 |
Taxes
In the past 12 months, CLB has paid $12.42 million in taxes.
| Income Tax | 12.42M |
| Effective Tax Rate | 29.14% |
Stock Price Statistics
The stock price has decreased by -25.06% in the last 52 weeks. The beta is 1.46, so CLB's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -25.06% |
| 50-Day Moving Average | 11.52 |
| 200-Day Moving Average | 14.18 |
| Relative Strength Index (RSI) | 59.25 |
| Average Volume (20 Days) | 505,370 |
Short Selling Information
The latest short interest is 8.32 million, so 17.73% of the outstanding shares have been sold short.
| Short Interest | 8.32M |
| Short Previous Month | 7.52M |
| Short % of Shares Out | 17.73% |
| Short % of Float | 17.93% |
| Short Ratio (days to cover) | 18.08 |
Income Statement
In the last 12 months, CLB had revenue of $517.38 million and earned $29.63 million in profits. Earnings per share was $0.62.
| Revenue | 517.38M |
| Gross Profit | 101.20M |
| Operating Income | 47.98M |
| Pretax Income | 39.81M |
| Net Income | 29.63M |
| EBITDA | 62.71M |
| EBIT | 47.98M |
| Earnings Per Share (EPS) | $0.62 |
Balance Sheet
The company has $31.19 million in cash and $178.54 million in debt, giving a net cash position of -$147.35 million or -$3.14 per share.
| Cash & Cash Equivalents | 31.19M |
| Total Debt | 178.54M |
| Net Cash | -147.35M |
| Net Cash Per Share | -$3.14 |
| Equity (Book Value) | 267.30M |
| Book Value Per Share | 5.61 |
| Working Capital | 132.91M |
Cash Flow
In the last 12 months, operating cash flow was $54.30 million and capital expenditures -$15.02 million, giving a free cash flow of $39.28 million.
| Operating Cash Flow | 54.30M |
| Capital Expenditures | -15.02M |
| Free Cash Flow | 39.28M |
| FCF Per Share | $0.84 |
Margins
Gross margin is 19.56%, with operating and profit margins of 9.27% and 5.73%.
| Gross Margin | 19.56% |
| Operating Margin | 9.27% |
| Pretax Margin | 8.24% |
| Profit Margin | 5.73% |
| EBITDA Margin | 12.12% |
| EBIT Margin | 9.27% |
| FCF Margin | 7.59% |
Dividends & Yields
This stock pays an annual dividend of $0.04, which amounts to a dividend yield of 0.32%.
| Dividend Per Share | $0.04 |
| Dividend Yield | 0.32% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.45% |
| Buyback Yield | 0.02% |
| Shareholder Yield | 0.34% |
| Earnings Yield | 5.10% |
| FCF Yield | 6.77% |
Analyst Forecast
The average price target for CLB is $12.50, which is -0.16% lower than the current price. The consensus rating is "Hold".
| Price Target | $12.50 |
| Price Target Difference | -0.16% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 3.45% |
| EPS Growth Forecast (5Y) | 14.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 9, 2010. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 9, 2010 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CLB has an Altman Z-Score of 3.19 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.19 |
| Piotroski F-Score | 6 |